Enlitic (ASX:ENL) has secured a A$15m conditional placement and will convert its A$10m note stack, leaving A$18m pro forma cash and no debt.
Small Caps Stocks
ECS Botanics (ASX:ECS) says new Hesse GMP guidance in Germany may tighten compliant cannabis supply and favour its integrated OzSun platform.
GreenTech Metals (ASX:GRE) locks in an 8,300m Pilbara drill program and pivots Munni Munni toward a copper-PGE concentrate story.
Racura Oncology (ASX:RAC) secures Bellberry ethics approval for HARNESS-1, activating Chris O’Brien Lifehouse and Austin Health for its EGFR lung cancer trial.
Motio (ASX:MXO) posted its highest-ever revenue month in June 2026 and Q1 FY27 forward bookings jumped 20.3% as operating leverage emerges.
Mamba Exploration (ASX:M24) expands Meeka East tenure by 10km² and sets a late-July heritage survey ahead of a 50-hole RC drill program.
OncoSil Medical (ASX:OSL) has filed its FDA Humanitarian Device Exemption submission for dCCA, with the agency signalling a 45-day review window.
Maverick Minerals Australia (ASX:M96) has completed its A$2.7m acquisition of the Viper Project in the WA1 Resources-anchored West Arunta region.
Island Pharmaceuticals (ASX:ILA) has secured a Singapore patent covering ISLA-101 for Dengue and Chikungunya, widening the commercial pitch across Asia-Pacific.
ABx Group (ASX:ABX) says its ALCORE process can produce hydrogen fluoride at US$1,000-1,600/t, implying 30-60% operating margins against acidspar competitors.
